Table 1.
Clinical demographics for Keck subset of patients.
| Variable | Category | Value |
|---|---|---|
| Age | 71.4 (53.4–86.1) | |
| BMI | 24.9 (21.2–36.9) | |
| Hgb | 11.1 (5.1–15.0) | |
| HCT | 34.2 (18.3–46.3) | |
| WBC | 7.6 (4.8–20.4) | |
| Platelets | 201.5 (57–387) | |
| BUN | 22.5 (13–70) | |
| Creatinine | 1.2 (0.5–3.1) | |
| Race | Caucasian | 20 |
| Asian | 2 | |
| Gender | Male | 18 |
| Female | 4 | |
| Smoker | Previous | 14 |
| Current | 4 | |
| Never | 4 | |
| Neoadjuvant Chemo | Yes | 10 |
| No | 12 | |
| Surgical Procedure | Anterior Exenteration | 1 |
| Radical Cystectomy | 4 | |
| Robotic Radical Cystectimy | 17 | |
| Urinary Diversion | Studer | 9 |
| Ileal Conduit | 11 | |
| Indiana Pouch | 2 | |
| Pure Urothelial (CS/PS) | 7/4 | |
| Predominant Histology (CS/PS) | No Tumor | 2/9 |
| Urothelial | 17/11 | |
| Other | 3/1 | |
| Plasmacytoid | 0/1 | |
| Squamous (CS/PS) | Absent | 16/12 |
| Present | 2/1 | |
| NA | 4/9 | |
| Glandular (CS/PS) | Absent | 16/12 |
| Present | 2/1 | |
| NA | 4/9 | |
| Neuro (CS/PS) | Absent | 18/12 |
| Present | 1/1 | |
| NA | 3/9 | |
| Subgroup (CS/PS) | OC | 16/15 |
| EV | 4/3 | |
| N+ | 2/4 | |
| T Stage (CS/PS) | T0 | 2/9 |
| Ta | 2/0 | |
| Tis | 1/4 | |
| T1 | 1/2 | |
| T2a | 11/0 | |
| T2b | 0/1 | |
| T3a | 0/3 | |
| T3b | 2/1 | |
| T4a | 3/2 | |
| N Stage (CS/PS) | NX | 2/0 |
| N0 | 19/18 | |
| N2 | 1/4 |
Abbreviations: CS, clinical staging; PS, pathological staging; OC, organ confined; EV, extravesical; N+, node positive; BMI, body mass index; Hgb, hemoglobin; HCT, hematocrit; WBC, white blood cell; BUN, blood urea nitrogen.